|
FGD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.107200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.162400E-01 |
| Normal-vs-Stage2 |
2.661800E-01 |
| Normal-vs-Stage3 |
6.477600E-01 |
| Normal-vs-Stage4 |
8.358600E-01 |
| Stage1-vs-Stage2 |
8.059400E-01 |
| Stage1-vs-Stage3 |
4.814000E-01 |
| Stage1-vs-Stage4 |
2.693800E-01 |
| Stage2-vs-Stage3 |
4.399400E-01 |
| Stage2-vs-Stage4 |
2.609800E-01 |
| Stage3-vs-Stage4 |
5.564600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.733400E-01 |
| Normal-vs-AfricanAmerican |
5.820800E-01 |
| Normal-vs-Asian |
2.123000E-01 |
| Caucasian-vs-AfricanAmerican |
3.330000E-01 |
| Caucasian-vs-Asian |
4.832400E-01 |
| AfricanAmerican-vs-Asian |
1.640210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.957400E-01 |
| Normal-vs-Female |
2.206400E-01 |
| Male-vs-Female |
3.344400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.593600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.502400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.770400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.613400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.320600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.615400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.310200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.103600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.930200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.639200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.905800E-02 |
| Classical-VS-Follicular |
3.61670000004199E-06 |
| Classical-VS-Other |
2.872400E-01 |
| Classical-VS-Normal |
5.951200E-01 |
| Tall-VS-Follicular |
1.140760E-01 |
| Tall-VS-Other |
7.553600E-01 |
| Tall-VS-Normal |
1.454170E-01 |
| Follicular-VS-Other |
6.657400E-01 |
| Follicular-VS-Normal |
9.631400E-04 |
| Other-VS-Normal |
2.710400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.339830E-01 |
| Normal-vs-N1 |
5.762200E-01 |
| N0-vs-N1 |
4.935400E-01 |
|
|
